Cargando…

Metabolites of Latilactobacillus curvatus BYB3 and Indole Activate Aryl Hydrocarbon Receptor to Attenuate Lipopolysaccharide-Induced Intestinal Barrier Dysfunction

This study aimed to investigate the effects of the metabolites of Latilactobacillus curvatus BYB3 and indole-activated aryl hydrocarbon receptor (AhR) to increase the tight junction (TJ) proteins in an in vitro model of intestinal inflammation. In a Western blot assay, the metabolites of L. curvatus...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xing, Yong, Cheng Chung, Oh, Sejong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Food Science of Animal Resources 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647186/
https://www.ncbi.nlm.nih.gov/pubmed/36415578
http://dx.doi.org/10.5851/kosfa.2022.e51
_version_ 1784827331492184064
author Wang, Xing
Yong, Cheng Chung
Oh, Sejong
author_facet Wang, Xing
Yong, Cheng Chung
Oh, Sejong
author_sort Wang, Xing
collection PubMed
description This study aimed to investigate the effects of the metabolites of Latilactobacillus curvatus BYB3 and indole-activated aryl hydrocarbon receptor (AhR) to increase the tight junction (TJ) proteins in an in vitro model of intestinal inflammation. In a Western blot assay, the metabolites of L. curvatus BYB3 reduced the TJ demage in lipoploysaccharide (LPS) stimulated-Caco-2 cells. This reduction was a result of upregulating the expression of TJ-associated proteins and suppressing the nuclear factor-κB signaling. Immunofluorescence images consistently revealed that LPS disrupted and reduced the expression of TJ proteins, while the metabolites of L. curvatus BYB3 and indole reversed these alterations. The protective effects of L. curvatus BYB3 were observed on the intestinal barrier function when measuring transepithelial electrical resistance. Using high-performance liquid chromatography analysis the metabolites, the indole-3-latic acid and indole-3-acetamide concentrations were found to be 1.73±0.27 mg/L and 0.51±0.39 mg/L, respectively. These findings indicate that the metabolites of L. curvatus BYB3 have increasing mRNA expressions of cytochrome P450 1A1 (CYP1A1) and AhR, and may thus be applicable for therapy of various inflammatory gut diseases as postbiotics.
format Online
Article
Text
id pubmed-9647186
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean Society for Food Science of Animal Resources
record_format MEDLINE/PubMed
spelling pubmed-96471862022-11-21 Metabolites of Latilactobacillus curvatus BYB3 and Indole Activate Aryl Hydrocarbon Receptor to Attenuate Lipopolysaccharide-Induced Intestinal Barrier Dysfunction Wang, Xing Yong, Cheng Chung Oh, Sejong Food Sci Anim Resour SPECIAL SECTION ARTICLE: New concept of probiotics for human and animal health This study aimed to investigate the effects of the metabolites of Latilactobacillus curvatus BYB3 and indole-activated aryl hydrocarbon receptor (AhR) to increase the tight junction (TJ) proteins in an in vitro model of intestinal inflammation. In a Western blot assay, the metabolites of L. curvatus BYB3 reduced the TJ demage in lipoploysaccharide (LPS) stimulated-Caco-2 cells. This reduction was a result of upregulating the expression of TJ-associated proteins and suppressing the nuclear factor-κB signaling. Immunofluorescence images consistently revealed that LPS disrupted and reduced the expression of TJ proteins, while the metabolites of L. curvatus BYB3 and indole reversed these alterations. The protective effects of L. curvatus BYB3 were observed on the intestinal barrier function when measuring transepithelial electrical resistance. Using high-performance liquid chromatography analysis the metabolites, the indole-3-latic acid and indole-3-acetamide concentrations were found to be 1.73±0.27 mg/L and 0.51±0.39 mg/L, respectively. These findings indicate that the metabolites of L. curvatus BYB3 have increasing mRNA expressions of cytochrome P450 1A1 (CYP1A1) and AhR, and may thus be applicable for therapy of various inflammatory gut diseases as postbiotics. Korean Society for Food Science of Animal Resources 2022-11 2022-11-01 /pmc/articles/PMC9647186/ /pubmed/36415578 http://dx.doi.org/10.5851/kosfa.2022.e51 Text en © Korean Society for Food Science of Animal Resources https://creativecommons.org/licenses/by-nc/3.0/This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle SPECIAL SECTION ARTICLE: New concept of probiotics for human and animal health
Wang, Xing
Yong, Cheng Chung
Oh, Sejong
Metabolites of Latilactobacillus curvatus BYB3 and Indole Activate Aryl Hydrocarbon Receptor to Attenuate Lipopolysaccharide-Induced Intestinal Barrier Dysfunction
title Metabolites of Latilactobacillus curvatus BYB3 and Indole Activate Aryl Hydrocarbon Receptor to Attenuate Lipopolysaccharide-Induced Intestinal Barrier Dysfunction
title_full Metabolites of Latilactobacillus curvatus BYB3 and Indole Activate Aryl Hydrocarbon Receptor to Attenuate Lipopolysaccharide-Induced Intestinal Barrier Dysfunction
title_fullStr Metabolites of Latilactobacillus curvatus BYB3 and Indole Activate Aryl Hydrocarbon Receptor to Attenuate Lipopolysaccharide-Induced Intestinal Barrier Dysfunction
title_full_unstemmed Metabolites of Latilactobacillus curvatus BYB3 and Indole Activate Aryl Hydrocarbon Receptor to Attenuate Lipopolysaccharide-Induced Intestinal Barrier Dysfunction
title_short Metabolites of Latilactobacillus curvatus BYB3 and Indole Activate Aryl Hydrocarbon Receptor to Attenuate Lipopolysaccharide-Induced Intestinal Barrier Dysfunction
title_sort metabolites of latilactobacillus curvatus byb3 and indole activate aryl hydrocarbon receptor to attenuate lipopolysaccharide-induced intestinal barrier dysfunction
topic SPECIAL SECTION ARTICLE: New concept of probiotics for human and animal health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647186/
https://www.ncbi.nlm.nih.gov/pubmed/36415578
http://dx.doi.org/10.5851/kosfa.2022.e51
work_keys_str_mv AT wangxing metabolitesoflatilactobacilluscurvatusbyb3andindoleactivatearylhydrocarbonreceptortoattenuatelipopolysaccharideinducedintestinalbarrierdysfunction
AT yongchengchung metabolitesoflatilactobacilluscurvatusbyb3andindoleactivatearylhydrocarbonreceptortoattenuatelipopolysaccharideinducedintestinalbarrierdysfunction
AT ohsejong metabolitesoflatilactobacilluscurvatusbyb3andindoleactivatearylhydrocarbonreceptortoattenuatelipopolysaccharideinducedintestinalbarrierdysfunction